The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population

被引:37
作者
Nordborg, C
Johansson, H
Petursdottir, V
Nordborg, E
机构
[1] Sahlgrens Univ Hosp, Dept Clin Pathol, S-41345 Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Dept Rheumatol, S-41345 Gothenburg, Sweden
[3] Univ Iceland, Dept Pathol, Reykjavik, Iceland
关键词
giant cell arteritis; epidemiology; incidence; age;
D O I
10.1093/rheumatology/keg172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The incidence of giant cell arteritis (GCA) increases with age. The aim of the present study was to investigate whether the increasing incidence of biopsyproven GCA in Goteborg, Sweden, could be explained in terms of a change in the age composition of the general population. Methods. All cases of biopsy-verified GCA between 1976 and 1995 were recorded. The annual incidence was calculated for women and men aged 50 yr or older and its relationship with the age composition of the general population was tested statistically. Results. There was a significant positive correlation between age and the risk of developing GCA. In the general population, there was a shift towards higher age; in 1976, the mean age of people 50 yr or older was 63.2 (men) and 65.0 (women), whereas in 1995 it was 65.0 (men) and 68.1 (women). After compensating for this, the incidence of biopsy-proven GCA still increased significantly. Moreover, for women aged 50 yr or older, the risk of developing the disease increased more among younger subjects than older ones. Conclusions. The increase in the incidence of biopsy-proven GCA between 1976 and 1995 could not be explained merely in terms of the increasing age of the general population. It is most probably related to an increase in the influence of other factors.
引用
收藏
页码:549 / 552
页数:4
相关论文
共 17 条
[1]   HOW DOES PREVIOUS CORTICOSTEROID TREATMENT AFFECT THE BIOPSY FINDINGS IN GIANT-CELL (TEMPORAL) ARTERITIS [J].
ACHKAR, AA ;
LIE, JT ;
HUNDER, GG ;
OFALLON, WM ;
GABRIEL, SE .
ANNALS OF INTERNAL MEDICINE, 1994, 120 (12) :987-992
[2]   GIANT-CELL ARTERITIS IN ICELAND - AN EPIDEMIOLOGIC AND HISTOPATHOLOGIC ANALYSIS [J].
BALDURSSON, O ;
STEINSSON, K ;
BJORNSSON, J ;
LIE, JT .
ARTHRITIS AND RHEUMATISM, 1994, 37 (07) :1007-1012
[3]   GIANT-CELL ARTERITIS, TEMPORAL ARTERITIS, AND POLYMYALGIA RHEUMATICA IN A DANISH COUNTY - A PROSPECTIVE INVESTIGATION, 1982-1985 [J].
BOESEN, P ;
SORENSEN, SF .
ARTHRITIS AND RHEUMATISM, 1987, 30 (03) :294-299
[4]  
FRANZEN P, 1992, J RHEUMATOL, V19, P273
[5]   GIANT-CELL ARTERITIS IN MEDITERRANEAN COUNTRIES - COMMENT [J].
GONZALEZGAY, MA ;
ALONSO, MD ;
AGUERO, JJ ;
BAL, M ;
FERNANDEZCAMBLOR, B ;
SANCHEZANDRADE, A .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1249-1249
[6]  
*GOT MUN OFF, 1977, STAT YB GOT
[7]   The incidence and clinical characteristics of peripheral arthritis in polymyalgia rheumatics and temporal arteritis: a prospective study of 231 cases [J].
Gran, JT ;
Myklebust, G .
RHEUMATOLOGY, 2000, 39 (03) :283-287
[8]  
Gran JT, 1997, J RHEUMATOL, V24, P1739
[9]  
Haugeberg G, 2000, J RHEUMATOL, V27, P2624
[10]  
LIE JT, 1970, ARCH PATHOL, V90, P278